Compare BRKR & AFRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRKR | AFRM |
|---|---|---|
| Founded | 1960 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Business Services |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 19.6B |
| IPO Year | 2000 | 2020 |
| Metric | BRKR | AFRM |
|---|---|---|
| Price | $33.79 | $42.54 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 27 |
| Target Price | $49.54 | ★ $85.08 |
| AVG Volume (30 Days) | 1.9M | ★ 5.4M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.57% | N/A |
| EPS Growth | N/A | ★ 108.98 |
| EPS | N/A | ★ 0.60 |
| Revenue | $1,895,600,000.00 | ★ $3,224,412,000.00 |
| Revenue This Year | $6.27 | $30.78 |
| Revenue Next Year | $3.78 | $24.09 |
| P/E Ratio | ★ N/A | $73.05 |
| Revenue Growth | N/A | ★ 38.80 |
| 52 Week Low | $28.53 | $30.90 |
| 52 Week High | $56.22 | $100.00 |
| Indicator | BRKR | AFRM |
|---|---|---|
| Relative Strength Index (RSI) | 35.81 | 33.85 |
| Support Level | $32.37 | N/A |
| Resistance Level | $35.15 | $79.27 |
| Average True Range (ATR) | 1.62 | 2.55 |
| MACD | 0.27 | 0.13 |
| Stochastic Oscillator | 25.81 | 7.95 |
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
Founded in 2012, Affirm is a market leader in the buy-now, pay-later space with around $36 billion in transaction volume in fiscal 2025. Affirm offers both zero-interest financing, which is merchant subsidized, and interest-bearing loans, which function as personal loans that are approved on a per-transaction basis. Over 70% of Affirm's transaction volume comes from its interest-bearing loans, which also comprise the majority of its revenue. Affirm primarily operates in the United States, which accounted for more than 95% of its revenue in 2025, but the firm has also expanded to Canada and the United Kingdom.